Cisatracurium Besylate Injection
Product Images NDC 72785-0008

This is a description of injectable medication called Cisatracurium Besylate, used for artificial respiration. The medication must be refrigerated at 2° to 8°C and should not be frozen, and it needs to be used within 21 days of being removed from refrigeration. Each mL of this medication contains 2mg of Cisatracurium Besylate, equivalent to the usual dosage, and the medication is a non-pyrogenic solution for intravenous injection. The package of the Cisatracurium Besylate warns that it is a Paralyzing Agent, and the medication should be discarded after use.*

Cisatracurium Besylate Injection is a sterile and nonpyrogenic solution that is administered by intravenous injection. It is used as a paralyzing agent for artificial respiration in surgical operations. This injection contains benzenesulfonic acid to adjust the pH level, and each milliliter of the injection contains cisatracurium besylate equivalent to 10 mg cisatracurium. The usual dosage of the injection is mentioned in the package insert, and it should be refrigerated at 2° to 8°C to protect it from light. Upon removal from refrigeration, it should be used within 21 days, and facilities for artificial respiration must be immediately available as it may cause respiratory arrest. This injection is manufactured in India.*

Cisatracurium Besylate Injection, USP is a medication produced by Zydus Pharmaceuticals. The text also includes some codes and numbers that may be related to the medication's packaging.*

This is a description of a medical product, specifically an injection, called "Cisatracurium Besylate Injection, USP" with a dosage of 200 mg/20mL (10mg/mL). It is intended for ICU use only and should only be administered intravenously. The injection is available in single-dose vials and is preservative-free. The product has a National Drug Code (NDC) of 7278500096. There are additional unclear characters and text in the provided data that could not be evaluated.*